158 related articles for article (PubMed ID: 24362053)
1. Risk of hepatobiliary cancer after solid organ transplant in the United States.
Koshiol J; Pawlish K; Goodman MT; McGlynn KA; Engels EA
Clin Gastroenterol Hepatol; 2014 Sep; 12(9):1541-9.e3. PubMed ID: 24362053
[TBL] [Abstract][Full Text] [Related]
2. Spectrum of cancer risk among US solid organ transplant recipients.
Engels EA; Pfeiffer RM; Fraumeni JF; Kasiske BL; Israni AK; Snyder JJ; Wolfe RA; Goodrich NP; Bayakly AR; Clarke CA; Copeland G; Finch JL; Fleissner ML; Goodman MT; Kahn A; Koch L; Lynch CF; Madeleine MM; Pawlish K; Rao C; Williams MA; Castenson D; Curry M; Parsons R; Fant G; Lin M
JAMA; 2011 Nov; 306(17):1891-901. PubMed ID: 22045767
[TBL] [Abstract][Full Text] [Related]
3. Incidence and risk factors for hepatocellular carcinoma after solid organ transplantation.
Hoffmann CJ; Subramanian AK; Cameron AM; Engels EA
Transplantation; 2008 Sep; 86(6):784-90. PubMed ID: 18813102
[TBL] [Abstract][Full Text] [Related]
4. Increased risk of hepatobiliary cancers after hospitalization for autoimmune disease.
Castro FA; Liu X; Försti A; Ji J; Sundquist J; Sundquist K; Koshiol J; Hemminki K
Clin Gastroenterol Hepatol; 2014 Jun; 12(6):1038-45.e7. PubMed ID: 24246767
[TBL] [Abstract][Full Text] [Related]
5. Sebaceous Carcinoma Incidence and Survival Among Solid Organ Transplant Recipients in the United States, 1987-2017.
Sargen MR; Cahoon EK; Lynch CF; Tucker MA; Goldstein AM; Engels EA
JAMA Dermatol; 2020 Dec; 156(12):1307-1314. PubMed ID: 33146669
[TBL] [Abstract][Full Text] [Related]
6. Cancer Risk After Pediatric Solid Organ Transplantation.
Yanik EL; Smith JM; Shiels MS; Clarke CA; Lynch CF; Kahn AR; Koch L; Pawlish KS; Engels EA
Pediatrics; 2017 May; 139(5):. PubMed ID: 28557749
[TBL] [Abstract][Full Text] [Related]
7. Risk of Colorectal Cancer After Solid Organ Transplantation in the United States.
Safaeian M; Robbins HA; Berndt SI; Lynch CF; Fraumeni JF; Engels EA
Am J Transplant; 2016 Mar; 16(3):960-7. PubMed ID: 26731613
[TBL] [Abstract][Full Text] [Related]
8. Risk of hepato-pancreato-biliary cancer is increased by primary sclerosing cholangitis in patients with inflammatory bowel disease: A population-based cohort study.
Yu J; Refsum E; Helsingen LM; Folseraas T; Ploner A; Wieszczy P; Barua I; Jodal HC; Melum E; Løberg M; Blom J; Bretthauer M; Adami HO; Kalager M; Ye W
United European Gastroenterol J; 2022 Mar; 10(2):212-224. PubMed ID: 35107865
[TBL] [Abstract][Full Text] [Related]
9. Associations between autoimmune conditions and hepatobiliary cancer risk among elderly US adults.
McGee EE; Castro FA; Engels EA; Freedman ND; Pfeiffer RM; Nogueira L; Stolzenberg-Solomon R; McGlynn KA; Hemminki K; Koshiol J
Int J Cancer; 2019 Feb; 144(4):707-717. PubMed ID: 30155920
[TBL] [Abstract][Full Text] [Related]
10. Mortality and cancer risk related to primary sclerosing cholangitis in a Swedish population-based cohort.
de Valle MB; Björnsson E; Lindkvist B
Liver Int; 2012 Mar; 32(3):441-8. PubMed ID: 22098097
[TBL] [Abstract][Full Text] [Related]
11. Plasma cell neoplasms in US solid organ transplant recipients.
Engels EA; Clarke CA; Pfeiffer RM; Lynch CF; Weisenburger DD; Gibson TM; Landgren O; Morton LM
Am J Transplant; 2013 Jun; 13(6):1523-32. PubMed ID: 23635036
[TBL] [Abstract][Full Text] [Related]
12. The association between frequency of vigorous physical activity and hepatobiliary cancers in the NIH-AARP Diet and Health Study.
Behrens G; Matthews CE; Moore SC; Freedman ND; McGlynn KA; Everhart JE; Hollenbeck AR; Leitzmann MF
Eur J Epidemiol; 2013 Jan; 28(1):55-66. PubMed ID: 23354983
[TBL] [Abstract][Full Text] [Related]
13. De Novo Colorectal and Pancreatic Cancer in Liver-Transplant Recipients: Identifying the Higher-Risk Populations.
Nasser-Ghodsi N; Mara K; Watt KD
Hepatology; 2021 Aug; 74(2):1003-1013. PubMed ID: 33544906
[TBL] [Abstract][Full Text] [Related]
14. The risk of hepatocellular carcinoma among individuals with acquired immunodeficiency syndrome in the United States.
Sahasrabuddhe VV; Shiels MS; McGlynn KA; Engels EA
Cancer; 2012 Dec; 118(24):6226-33. PubMed ID: 22736272
[TBL] [Abstract][Full Text] [Related]
15. Gallstones, cholecystectomy and risk of cancers of the liver, biliary tract and pancreas.
Chow WH; Johansen C; Gridley G; Mellemkjaer L; Olsen JH; Fraumeni JF
Br J Cancer; 1999 Feb; 79(3-4):640-4. PubMed ID: 10027343
[TBL] [Abstract][Full Text] [Related]
16. Excess risk of primary liver cancer in patients with diabetes mellitus.
Adami HO; Chow WH; Nyrén O; Berne C; Linet MS; Ekbom A; Wolk A; McLaughlin JK; Fraumeni JF
J Natl Cancer Inst; 1996 Oct; 88(20):1472-7. PubMed ID: 8841022
[TBL] [Abstract][Full Text] [Related]
17. Risk of myeloid neoplasms after solid organ transplantation.
Morton LM; Gibson TM; Clarke CA; Lynch CF; Anderson LA; Pfeiffer R; Landgren O; Weisenburger DD; Engels EA
Leukemia; 2014 Dec; 28(12):2317-23. PubMed ID: 24727673
[TBL] [Abstract][Full Text] [Related]
18. Familial liver and gall bladder cancer: a nationwide epidemiological study from Sweden.
Hemminki K; Li X
Gut; 2003 Apr; 52(4):592-6. PubMed ID: 12631675
[TBL] [Abstract][Full Text] [Related]
19. Pancreatic cancer among solid organ transplant recipients in the United States.
Tanaka T; Lynch CF; Yu KJ; Morawski BM; Hsieh MC; Alverson G; Austin AA; Zeng Y; Engels EA
J Cancer Res Clin Oncol; 2023 Jul; 149(7):3325-3333. PubMed ID: 35932302
[TBL] [Abstract][Full Text] [Related]
20. Spectrum of Nonkeratinocyte Skin Cancer Risk Among Solid Organ Transplant Recipients in the US.
Sargen MR; Cahoon EK; Yu KJ; Madeleine MM; Zeng Y; Rees JR; Lynch CF; Engels EA
JAMA Dermatol; 2022 Apr; 158(4):414-425. PubMed ID: 35262623
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
